![Ventilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention | Clinical Microbiology Reviews Ventilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention | Clinical Microbiology Reviews](https://journals.asm.org/cms/10.1128/cmr.00051-05/asset/2ac4e7e6-90cb-4244-968d-46f37c702869/assets/graphic/zcm0040621900003.jpeg)
Ventilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention | Clinical Microbiology Reviews
![Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common and what is the impact? | Critical Care | Full Text Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common and what is the impact? | Critical Care | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13054-021-03571-z/MediaObjects/13054_2021_3571_Fig1_HTML.png)
Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common and what is the impact? | Critical Care | Full Text
![Antimicrobial Stewardship for Ventilator Associated Pneumonia in Intensive Care (the ASPIC trial): study protocol for a randomised controlled trial | BMJ Open Antimicrobial Stewardship for Ventilator Associated Pneumonia in Intensive Care (the ASPIC trial): study protocol for a randomised controlled trial | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/13/2/e065293/F1.large.jpg)
Antimicrobial Stewardship for Ventilator Associated Pneumonia in Intensive Care (the ASPIC trial): study protocol for a randomised controlled trial | BMJ Open
![Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation - The Lancet Respiratory Medicine Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/asset/e84ec235-3c00-46fd-acab-0ae17ae0fc6d/gr1.gif)
Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation - The Lancet Respiratory Medicine
![Treatment of severe hospital-acquired and ventilator-associated pneumonia: a systematic review of inclusion and judgment criteria used in randomized controlled trials | Critical Care | Full Text Treatment of severe hospital-acquired and ventilator-associated pneumonia: a systematic review of inclusion and judgment criteria used in randomized controlled trials | Critical Care | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13054-017-1755-5/MediaObjects/13054_2017_1755_Fig1_HTML.gif)
Treatment of severe hospital-acquired and ventilator-associated pneumonia: a systematic review of inclusion and judgment criteria used in randomized controlled trials | Critical Care | Full Text
![International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia | European Respiratory Society International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia | European Respiratory Society](https://erj.ersjournals.com/content/erj/50/3/1700582/F2.large.jpg)
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia | European Respiratory Society
![Ceftolozane/tazobactam versus colistin in the treatment of ventilator-associated pneumonia due to extensively drug-resistant Pseudomonas aeruginosa | Scientific Reports Ceftolozane/tazobactam versus colistin in the treatment of ventilator-associated pneumonia due to extensively drug-resistant Pseudomonas aeruginosa | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-08307-9/MediaObjects/41598_2022_8307_Fig1_HTML.png)
Ceftolozane/tazobactam versus colistin in the treatment of ventilator-associated pneumonia due to extensively drug-resistant Pseudomonas aeruginosa | Scientific Reports
![Review of Hospital-Acquired, Ventilator-Associated, and Health Care–Associated Pneumonia in Immunocompetent Adults Review of Hospital-Acquired, Ventilator-Associated, and Health Care–Associated Pneumonia in Immunocompetent Adults](https://www.uspharmacist.com/CMSImagesContent/2006/7/0706_PneumoniaT2.jpg)
Review of Hospital-Acquired, Ventilator-Associated, and Health Care–Associated Pneumonia in Immunocompetent Adults
![Buy THE EFFECTS OF RESPIRATORY PHYSIOTHERAPY ON PREVENTION AND TREATMENT OF VENTILATOR ASSOCIATED PNEUMONIA FOR ICU PAT Book Online at Low Prices in India | THE EFFECTS OF RESPIRATORY PHYSIOTHERAPY ON PREVENTION Buy THE EFFECTS OF RESPIRATORY PHYSIOTHERAPY ON PREVENTION AND TREATMENT OF VENTILATOR ASSOCIATED PNEUMONIA FOR ICU PAT Book Online at Low Prices in India | THE EFFECTS OF RESPIRATORY PHYSIOTHERAPY ON PREVENTION](https://m.media-amazon.com/images/I/71M7toVf9tL.jpg)
Buy THE EFFECTS OF RESPIRATORY PHYSIOTHERAPY ON PREVENTION AND TREATMENT OF VENTILATOR ASSOCIATED PNEUMONIA FOR ICU PAT Book Online at Low Prices in India | THE EFFECTS OF RESPIRATORY PHYSIOTHERAPY ON PREVENTION
![Strategies in the prevention of ventilator-associated pneumonia - Diego J. Maselli, Marcos I. Restrepo, 2011 Strategies in the prevention of ventilator-associated pneumonia - Diego J. Maselli, Marcos I. Restrepo, 2011](https://journals.sagepub.com/cms/10.1177/1753465810395655/asset/images/large/10.1177_1753465810395655-fig1.jpeg)
Strategies in the prevention of ventilator-associated pneumonia - Diego J. Maselli, Marcos I. Restrepo, 2011
![Reconsidering ventilator-associated pneumonia from a new dimension of the lung microbiome - eBioMedicine Reconsidering ventilator-associated pneumonia from a new dimension of the lung microbiome - eBioMedicine](https://www.thelancet.com/cms/attachment/c9dadd9e-f2ad-4389-9559-af064099b668/gr1a_lrg.jpg)